Theriva Biologics Inc (TOVX)

[BooDog]

That bodes well for a couple of our bio's Citrati!!

Katherine Xu

So can you describe the interest level from industry, potential partners on this program?

Jeff Riley

Like I told you last quarter, we're talking to everybody Katherine at this point in time. I mean, there are discussions on for both drugs, from disparate companies. There's only a couple that are looking at both drugs together. The industry I think is beginning to look at licensing again. I think it's been pretty dry for the last two or three years from late stage Phase 2, Phase 3, the classic licensing deals. I think it's beginning to improve. Ken Frazier at Merck actually signaled that the other day that they were going to begin looking for things at Merck and I would guess that Pfizer said something similar as well in their earnings call. So I believe that the tide is going to turn for the big guys to start acquiring assets and filling their pipeline. So again, the only guidance I can give you is when we have a deal in hand and it becomes relevant, we'll announce it."

It is all about the FDA meeting and setting up the protocol. I would think they'd want some BP input through a CDA as well but we'll see how it goes. Fine tune this machine and get'r started!!

$SYN